Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 290.78M | 287.76M | 287.59M | 283.64M | 243.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 290.78M | 287.76M | 287.59M | 283.64M | 243.12M |
| Cost of Revenue | 110.82M | 109.66M | 116.62M | 115.02M | 96.07M |
| Gross Profit | 179.96M | 178.09M | 170.97M | 168.63M | 147.04M |
| SG&A Expenses | 79.63M | 78.81M | 78.46M | 77.38M | 71.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 224.11M | 221.78M | 226.10M | 222.99M | 196.95M |
| Operating Income | 66.67M | 65.98M | 61.49M | 60.65M | 46.16M |
| Income Before Tax | 63.10M | 62.44M | 29.12M | 28.72M | 42.53M |
| Income Tax Expenses | 16.26M | 16.09M | 21.38M | 21.08M | 10.07M |
| Earnings from Continuing Operations | 46.83M | 46.35M | 7.75M | 7.64M | 32.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.83M | 46.35M | 7.75M | 7.64M | 32.46M |
| EBIT | 66.67M | 65.98M | 61.49M | 60.65M | 46.16M |
| EBITDA | 84.28M | 83.41M | 75.46M | 74.42M | 60.02M |
| EPS Basic | 0.08 | 0.08 | 0.01 | 0.01 | 0.06 |
| Normalized Basic EPS | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| EPS Diluted | 0.08 | 0.08 | 0.01 | 0.01 | 0.06 |
| Normalized Diluted EPS | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| Average Basic Shares Outstanding | 584.95M | 584.95M | 583.36M | 583.36M | 580.58M |
| Average Diluted Shares Outstanding | 589.39M | 589.39M | 587.82M | 587.82M | 584.54M |
| Dividend Per Share | 0.06 | 0.06 | 0.07 | 0.07 | 0.05 |
| Payout Ratio | 47.04% | 47.04% | 205.61% | 205.61% | 62.70% |
